Michelle Moser created a new blog entry
on January 12 2024 at 01:35 AM public
Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study the Mechanistic Target of Rapamycin (mTOR) in diabetes and...
Michelle Moser created a new blog entry
on January 12 2024 at 01:34 AM public
Substrate-Chromogens for Immunohistochemistry
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its innovative line of Chromogenic Substrates for...
Michelle Moser created a new blog entry
on December 06 2023 at 03:42 AM public
Embedding Resins and Kits
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the expansion of its portfolio to include a comprehensive line of Embedding...
Michelle Moser created a new blog entry
on December 06 2023 at 03:40 AM public
New Solutions for Glucose Homeostasis Research
CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its comprehensive research solutions for the scientific community to gain insights...
Michelle Moser created a new blog entry
on November 20 2023 at 03:36 AM public
New Solutions for Studying Anabolism
CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study Anabolism in diabetes. The new solutions can help...
Michelle Moser created a new blog entry
on November 20 2023 at 03:35 AM public
3D Image Analysis Services For Bioimaging Research
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its 3D Image Analysis Services for researchers, from data processing...
Michelle Moser created a new blog entry
on October 26 2023 at 02:03 AM public
New Services to Study Catabolism in Diabetes
CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new Catabolism research services, which offer researchers a comprehensive range...
Michelle Moser created a new blog entry
on October 26 2023 at 02:00 AM public
3D Tissue Imaging Services
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the launch of its new 3D Tissue Imaging Services to researchers with comprehensive...
Michelle Moser created a new blog entry
on September 18 2023 at 10:44 PM public
New Metabolic Homeostasis Research Solutions
CD BioSciences, a US-based CRO serving the global life science research community, has announced a series of new solutions for metabolic homeostasis, including Regulator Characterization,...
Michelle Moser created a new blog entry
on September 18 2023 at 10:42 PM public
New Single Molecule Fluorescence Imaging Technology
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the availability of its new services based on Single Molecule Fluorescence Imaging...
Michelle Moser created a new blog entry
on August 24 2023 at 03:55 AM public
Research Solutions on Mitotic Catastrophe
CD BioSciences, a US-based CRO serving the global life science research community, has announced a series of new solutions on mitotic catastrophe, including Regulator Identification, Chemical...
Michelle Moser created a new blog entry
on August 24 2023 at 03:53 AM public
New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, introduced its new services based on super-resolution imaging technology to assist researchers...
View More
arrow_forward